Their integrated nutritional guidance addresses the dietary changes that often come with GLP-1 therapy
When food remains in the stomach for extended periods of time, patients may develop severe nausea, vomiting, dehydration, malnutrition, abdominal swelling, and painful digestive complications requiring hospitalization or emergency treatment
A poorly designed protocol can lead to receptor downregulation, conflicting signals, or simply wasted resources
3 These weight-loss results are similar to those achieved with the 2.4 mg injection of Wegovy and higher than those with Rybelsus, because the daily 25 mg dose is high enough to offset the low absorption with the pill
Physicians across all different specialties are writing these GLP1RA scripts and for a variety of indications